Finasteride for women: who may be offered it, what the studies show and the pregnancy rules

Can women take finasteride for hair loss? How it lowers DHT, why female pattern hair loss responds differently, what the 1 mg and 5 mg studies found, who a dermatologist might consider, the pregnancy rules, side effects and what makes sense in Malaysia.

Rambut editorial team ·

Finasteride is best known as a tablet for male pattern baldness. Yet many women in Malaysia who are losing hair come across it in forums, in a friend's story or on an online marketplace, and ask a reasonable question: if it works for men, could it work for me? The honest answer is more complicated than yes or no. Finasteride is not licensed for women's hair loss in most countries, it must never be used in pregnancy, and the studies in women point in different directions. At the same time, some dermatologists do prescribe it off-label for carefully chosen women, usually after menopause.

This guide explains how finasteride works, why female pattern hair loss responds differently from male pattern baldness, what the trials actually found, who might be considered, the pregnancy rules, side effects, how it compares with other options and what makes sense in Malaysia. It is general information, not personal medical advice. For background, see hair loss in women, female pattern hair loss treatment and finasteride for hair loss.

The short answer

Finasteride lowers the hormone DHT by blocking the type 2 form of the enzyme 5-alpha reductase 1. In men this slows pattern baldness and often thickens hair. In women the evidence is weaker and mixed. A well-run one-year placebo-controlled trial of finasteride 1 mg in 137 postmenopausal women found no benefit 2, and a Cochrane review judged finasteride no more effective than placebo for female pattern hair loss, based on low quality evidence 3. Smaller uncontrolled studies using higher doses, 2.5 mg to 5 mg a day, reported improvement in many women, including a Korean study of 87 women 4 5. Finasteride can harm the development of a male baby, so it is not used in women who are pregnant or could become pregnant without reliable contraception, and pregnant women should not handle broken tablets 6 7. For most women, topical minoxidil remains the first treatment with the strongest evidence 3. Finasteride, if used at all, is a specialist decision.

How finasteride works

Testosterone circulates in both men and women. In the skin and hair follicles, the enzyme 5-alpha reductase converts some of it into dihydrotestosterone, or DHT, a more potent androgen. There are two main forms of the enzyme. Finasteride blocks mainly the type 2 form, which lowers DHT in the blood and in the scalp 1 8.

In genetically sensitive scalp follicles, DHT shortens the growth phase of the hair cycle. Each new hair grows for less time and comes from a smaller follicle, so hairs become shorter, finer and lighter. This process is called miniaturisation 9. Lowering DHT can slow it. Dutasteride, a related drug, blocks both forms of the enzyme. See DHT and hair loss and finasteride vs dutasteride.

Why women are different

Female pattern hair loss looks and behaves differently from male pattern baldness. Women usually keep their front hairline and notice a widening parting, thinning over the crown and a smaller ponytail. Doctors describe it with the Ludwig scale or similar grading systems 10. See the Ludwig scale.

The role of androgens is also less clear in women. Many women with pattern thinning have completely normal hormone levels, and researchers believe other factors, including genetics, ageing and possibly oestrogen changes, play a part 9 11. This may explain why a drug that lowers DHT helps most men but gives inconsistent results in women.

Doctors often divide women into two groups:

  • Women with signs of excess androgens. These include acne, excess facial or body hair, irregular periods or polycystic ovary syndrome. Anti-androgen treatment makes more biological sense here. See PCOS and hair loss.
  • Normoandrogenic women. Their hormone tests are normal. Most of the higher dose finasteride studies were in this group, often after menopause 4 12.

What the studies found

The negative trial: 1 mg after menopause

The most rigorous study remains a 2000 multicentre trial in the United States. It randomised 137 postmenopausal women aged 41 to 60 to finasteride 1 mg a day or placebo for one year. Hair counts, photographs, the women's own ratings and scalp biopsies showed no difference between the groups. Both groups lost hair over the year 2. This is the main reason the 1 mg dose used for men is not considered effective for postmenopausal women.

Higher doses: more encouraging but weaker designs

Later studies tried higher doses:

  • Korea, 2011. 87 normoandrogenic women, both before and after menopause, took 5 mg a day for 12 months. Average hair density rose from 90 to 107 hairs per square centimetre and hair thickness also increased. About 81% looked improved in photographs, mostly slightly. Four women reported mild side effects such as headache, irregular periods, dizziness and increased body hair 4.
  • Portugal, 2013. 40 postmenopausal women with normal hormone levels took 5 mg a day for 18 months. Most reported moderate or significant improvement by six months. Four reported a lasting drop in libido and one had a rise in liver enzymes 12.
  • Switzerland, 2004. Just five postmenopausal women took 2.5 mg or 5 mg a day, and all improved 13.
  • Italy, 2006. 37 premenopausal women took 2.5 mg a day together with a contraceptive pill containing drospirenone. About 62% showed some improvement at 12 months. The authors could not tell whether the higher dose or the anti-androgen pill made the difference 14.

None of these studies had a placebo group, which matters because hair loss naturally fluctuates and people tend to report improvement when they expect it.

What reviews conclude

A 2019 systematic review of 65 studies involving 2,683 women found that most randomised trials of finasteride in women were for hirsutism or polycystic ovary syndrome rather than hair loss. Doses in hair loss studies ranged from 0.5 mg to 5 mg a day, usually for 6 to 12 months, and the authors called for long-term studies 5. A 2023 review of 14 studies concluded that 5 mg a day could help normoandrogenic women, especially combined with treatments such as minoxidil 15. An earlier pharmacy review noted that the two controlled studies showed no benefit, and that success had mostly been reported in uncontrolled studies 7. The Cochrane review's conclusion, finasteride no better than placebo on low quality evidence, still stands as the cautious summary 3.

A 2025 Canadian consensus included oral and topical finasteride among the interventions it recommended for androgenetic alopecia in adults, alongside minoxidil and others, but this was an expert agreement, not a new trial 16.

Comparison table: options for female pattern hair loss

OptionHow it worksEvidence in womenKey cautions
Topical minoxidil (2% or 5%)Prolongs the growth phase and enlarges folliclesBest evidence, from many randomised trialsEarly shedding, scalp irritation, unwanted facial hair
Oral finasterideLowers DHTMixed: no benefit at 1 mg after menopause, uncontrolled benefit at 2.5 to 5 mgNot in pregnancy, contraception essential, off-label
Topical finasterideLowers DHT in the scalp with less in the bloodLimited data in womenNot in pregnancy, scalp irritation
SpironolactoneBlocks androgen receptorsSmall trials and clinical experienceNot in pregnancy, blood pressure and potassium checks
Low dose oral minoxidilSame as topical, taken by mouthGrowing evidenceFacial hair, fluid retention, heart rate
Low level laser therapyLight energy to the follicleMixed resultsCost and time

Sources for the table: 3 5 17 18 9. See also minoxidil for women, spironolactone and oral minoxidil for women.

Who might be considered

Based on the studies, a dermatologist might discuss finasteride with:

  • Postmenopausal women with pattern thinning who have not improved enough with minoxidil, or who cannot use it 7.
  • Premenopausal women who are using reliable contraception and understand the pregnancy risk, often together with an anti-androgen contraceptive pill 14.
  • Women with signs of androgen excess, including hirsutism, where finasteride has more randomised trial data 5.
  • Some women with frontal fibrosing alopecia, a scarring hair loss of the hairline, where specialists sometimes use 5-alpha reductase inhibitors based on observational studies 5 19. See frontal fibrosing alopecia.

Finasteride is usually not appropriate for women who are pregnant, trying to conceive, breastfeeding, or unwilling to use contraception, and it does nothing for hair loss caused by iron deficiency, thyroid disease, telogen effluvium or alopecia areata 20.

The pregnancy rule

This is the most important safety point. Finasteride can cause problems with the development of a male baby's genitals during pregnancy 6. Women who are pregnant or might become pregnant should not take it. They should also avoid touching crushed or broken tablets, because this may harm the fetus. If it happens, wash the skin with soap and water straight away and call a doctor 6 21. A review of finasteride in women stresses that women of childbearing potential must use reliable contraception throughout treatment 7. Ask your doctor how long to wait after stopping before trying to conceive.

Side effects in women

In the women's studies, side effects were reported in a minority and were usually mild. They included headache, dizziness, irregular periods, increased body hair and reduced libido, and one study noted a rise in liver enzymes in one woman 4 12. Reviews describe finasteride as reasonably tolerated in both men and women, while noting that people should be told about possible short and long-term effects 1. Mood changes, including depression, are listed as a possible serious side effect 22. Product information also lists breast changes, such as lumps, pain or nipple discharge, as symptoms to report straight away 21. Because long-term data in women are limited 5, doctors usually ask about personal and family medical history, including breast health, before starting, and review regularly.

Topical finasteride

Topical finasteride sprays and solutions are designed to act mainly on the scalp. In men, a phase III trial found a 0.25% spray worked about as well as the 1 mg tablet over 24 weeks, with less effect on blood DHT 17 23. Data in women are much more limited, and topical forms still reach the bloodstream to some degree, so the same pregnancy precautions apply. See topical finasteride.

Step by step: what to expect

  1. Diagnosis first. A doctor confirms that the thinning is pattern hair loss, often with trichoscopy, and checks for other causes 20. See scalp analysis.
  2. Blood tests where needed. Iron stores, thyroid function and, if there are signs of androgen excess, hormone tests. See blood tests for hair loss and ferritin and women's hair loss.
  3. Usually minoxidil first. Most guidelines and reviews start with topical minoxidil 3 24.
  4. Discussion of finasteride if appropriate. Off-label use, dose, contraception, side effects and the uncertain evidence should all be explained.
  5. Baseline photos. Same light, same angles, parting and crown. See tracking hair loss with photos.
  6. Months 6 to 12. One review advises a 12-month trial to judge whether hair loss has stabilised, with further improvement possibly taking longer 7.
  7. Long-term. Benefits from any hair loss medicine generally last only while it is used.

Malaysian context

In Malaysia, finasteride is a prescription medicine, so the safe route is a consultation with a doctor, ideally a dermatologist for women, rather than buying tablets online. See finasteride in Malaysia. Products sold in Malaysia can be checked on the NPRA QUEST product search 25, and doctors can be checked on the Malaysian Medical Council register 26. No verified Malaysian price source exists for finasteride treatment in women, so ask for the cost of consultations, tests and medicine in writing.

Asian data are relevant here. The largest higher dose study in women came from Korea 4, although there are no Malaysian studies yet. Many Malaysian women wear a tudung or tie their hair back daily, and traction, heat and sweat can add to visible thinning without being the root cause. See hijab and hair loss. Women with PCOS, which is common, deserve a full assessment, as hair thinning may be one sign of a wider hormonal picture.

For assessment, consider a dermatologist or an experienced hair care centre in Kuala Lumpur, Penang or Sibu. See women's hair loss clinics in KL, women's hair loss in Penang and Sibu.

Common myths

  • "Finasteride works for women just like it does for men." The best controlled trial of 1 mg in postmenopausal women found no benefit 2.
  • "If my hormones are normal, anti-androgens cannot help." Several higher dose studies were in women with normal hormone levels, though without placebo groups 4 12.
  • "Topical finasteride is completely safe in pregnancy." It can still reach the bloodstream, so the same precautions apply 17.
  • "A stronger dose will work faster." Dose is a medical decision. Taking more than prescribed does not speed results 22.
  • "Finasteride is a hormone that will make me masculine." It reduces conversion to DHT. It is not testosterone, though side effects such as reduced libido can occur 12.

Practical checklist

  • Get a confirmed diagnosis of female pattern hair loss.
  • Check iron, thyroid and, if relevant, androgen levels.
  • Try or discuss topical minoxidil first.
  • If finasteride is suggested, ask about dose, off-label status and evidence.
  • Use reliable contraception if you could become pregnant.
  • Keep tablets away from pregnant women in your household.
  • Report mood changes, libido changes or other side effects promptly.
  • Take baseline photos and review at 6 and 12 months.
  • Buy medicines only from a registered pharmacy or doctor.

Summary

Finasteride for women sits in a grey zone. It lowers DHT, which drives male pattern baldness, but female pattern hair loss is less clearly driven by androgens. The 1 mg dose showed no benefit in postmenopausal women in a placebo-controlled trial 2, while higher doses of 2.5 mg to 5 mg helped many women in uncontrolled studies from Korea, Europe and elsewhere 4 12 14. It must not be used in pregnancy and requires reliable contraception in women who could conceive 6. For most women in Malaysia, the sensible path is a proper diagnosis, topical minoxidil as the first evidence-based option and a frank talk with a dermatologist about whether finasteride or another anti-androgen fits their situation. Results vary from person to person.

Frequently asked questions

Can women take finasteride for hair loss?

Some dermatologists prescribe it off-label for selected women, usually after menopause or with reliable contraception. It is not licensed for women's hair loss in most countries, and the evidence is mixed 5 7.

Does finasteride 1 mg work for women?

A one-year placebo-controlled trial in 137 postmenopausal women found no benefit from 1 mg a day, and a Cochrane review found finasteride no better than placebo on low quality evidence 2 3.

What about 2.5 mg or 5 mg a day?

Uncontrolled studies, including one of 87 Korean women on 5 mg a day, reported improvement in many women. Without placebo groups, these results are less certain 4 12.

Is finasteride safe in pregnancy?

No. It can affect the development of a male baby's genitals. Women who could become pregnant need reliable contraception, and pregnant women should not touch broken or crushed tablets 6 21.

What side effects do women report?

In studies, a minority reported mild headache, dizziness, irregular periods, increased body hair or reduced libido. Mood changes and breast changes should be reported to a doctor straight away 4 21.

Is topical finasteride better for women?

It is designed to act mainly on the scalp, but data in women are limited and some still reaches the blood, so pregnancy precautions remain 17 23.

What should women try first?

Topical minoxidil has the strongest evidence for female pattern hair loss. A doctor should also check for causes such as low iron or thyroid problems 3 20.

Can I buy finasteride online in Malaysia?

Finasteride is a prescription medicine. See a doctor, and check products on the NPRA QUEST search rather than buying from unverified sellers 25.

Sources

  1. PubMed (Gupta et al., J Dermatolog Treat, 2022). Finasteride for hair loss: a review, 2022. accessed 27 Oct 2026
  2. PubMed (Price et al., J Am Acad Dermatol, 2000). Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia, 2000. accessed 27 Oct 2026
  3. PubMed. Interventions for female pattern hair loss, Cochrane Database Syst Rev, 2016. accessed 27 Oct 2026
  4. PubMed (Yeon et al., J Eur Acad Dermatol Venereol, 2011). 5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss, 2011. accessed 27 Oct 2026
  5. PubMed (Hu et al., Int J Dermatol, 2019). The efficacy and use of finasteride in women: a systematic review, 2019. accessed 27 Oct 2026
  6. NHS. Fertility and pregnancy while taking finasteride. accessed 27 Oct 2026
  7. PubMed (Stout and Stumpf, Ann Pharmacother, 2010). Finasteride treatment of hair loss in women, 2010. accessed 27 Oct 2026
  8. DermNet. Finasteride. accessed 27 Oct 2026
  9. DermNet. Female pattern hair loss. accessed 27 Oct 2026
  10. PubMed. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex, Br J Dermatol, 1977. accessed 27 Oct 2026
  11. PubMed. Female pattern hair loss: A comprehensive review, Dermatol Ther, 2020. accessed 27 Oct 2026
  12. PubMed (Oliveira-Soares et al., Int J Trichology, 2013). Finasteride 5 mg/day Treatment of Patterned Hair Loss in Normo-androgenetic Postmenopausal Women, 2013. accessed 27 Oct 2026
  13. PubMed (Trüeb et al., Dermatology, 2004). Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women, 2004. accessed 27 Oct 2026
  14. PubMed (Iorizzo et al., Arch Dermatol, 2006). Finasteride treatment of female pattern hair loss, 2006. accessed 27 Oct 2026
  15. PubMed (Nobari et al., Adv Clin Exp Med, 2023). A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive age and postmenopausal women with hormonal and nonhormonal androgenetic alopecia, 2023. accessed 27 Oct 2026
  16. PubMed (Landells et al., J Cutan Med Surg, 2025). A Canadian Consensus on Androgenetic Alopecia: Approach and Management, 2025. accessed 27 Oct 2026
  17. PubMed (Gupta and Talukder, J Cosmet Dermatol, 2022). Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative?, 2022. accessed 27 Oct 2026
  18. PubMed. The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review, Clin Cosmet Investig Dermatol, 2023. accessed 27 Oct 2026
  19. DermNet. Frontal fibrosing alopecia. accessed 27 Oct 2026
  20. American Academy of Dermatology. Hair loss: Who gets and causes. accessed 27 Oct 2026
  21. MedlinePlus (US National Library of Medicine). Finasteride. accessed 27 Oct 2026
  22. NHS. Finasteride. accessed 27 Oct 2026
  23. PubMed. A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women, J Drugs Dermatol, 2018. accessed 27 Oct 2026
  24. PubMed. Female-pattern hair loss: therapeutic update, An Bras Dermatol, 2023. accessed 27 Oct 2026
  25. National Pharmaceutical Regulatory Agency (NPRA), Malaysia. QUEST 3+ Product Search. accessed 27 Oct 2026
  26. Malaysian Medical Council. Malaysian Medical Council (registered medical practitioners and specialists). accessed 27 Oct 2026

Educational content. Not medical advice.

Related reading

Women's Hair

Female pattern hair loss treatment: options with evidence

An in-depth guide to female pattern hair loss treatment: the biology of thinning, confirming the diagnosis, realistic goals, topical and oral minoxidil, anti-androgens, laser devices and other options, comparison tables, pros, cons and risks, a step-by-step plan, a timeline, Malaysian practical points, myths and a checklist.

Rambut editorial team ·

Women's Hair

Hair loss in women: the common causes, explained

An in-depth guide to hair loss in women: how hair grows, female pattern hair loss, shedding after a trigger, iron, thyroid and PCOS, hairstyles and the tudung, how to tell the types apart, treatments compared, timelines, the Malaysian context, myths, a checklist and FAQs.

Rambut editorial team ·

Minoxidil & Medicines

Minoxidil for women: use, expectations and cautions

An in-depth guide to minoxidil for women: the biology of female pattern hair loss, whether it is the right type, what the evidence says, 2% and 5% foam and solution compared, step-by-step use (including with a tudung), a month-by-month timeline, side effects, pros and risks, pregnancy, the Malaysian context, myths and a checklist.

Rambut editorial team ·

All articles